MDxHealth flags Nasdaq notice over US$35 million market value deficiency
MDXH•Potential delisting risk
Failure to cure by the deadline could trigger delisting procedures, subject to potential extra time or an appeal.
Nasdaq notice for market value shortfall
MDxHealth received a Nasdaq notice for failing to meet the US$35 million minimum market value requirement under Listing Rule 5550(b)(2).
Nasdaq flagged 30 consecutive business days of non-compliance based on market value from June 1 to July 17, 2026.
Compliance timeline and cure requirements
The stock remains listed for now, and the company has until Jan. 19, 2027 to regain compliance.
Compliance requires market value above US$35 million for at least 10 consecutive business days.
